Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma.
Ehrs
Per-Olof
PO
Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sundblad
Britt-Marie
BM
Larsson
Kjell
K
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000368:Aged; D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D015415:Biomarkers; D001944:Breath Tests; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D005260:Female; D000068298:Fluticasone; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000032:analysis; D011788:Quality of Life; D012720:Severity of Illness Index; D013147:Spirometry
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D009569:Nitric Oxide; D000068298:Fluticasone